Herbas VPB

Print
EN | LT
LT - BCMA ir CD3 prijungiančios molekulės
EN - BINDING MOLECULES FOR BCMA AND CD3

Legal status

Patent revoked (after opposition at EPO)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
A61P 35/02 (2006.01)
A61P 37/00 (2006.01)
European patent
(11) Number of the document 2780375
(13) Kind of document T
(96) European patent application number 12805432.7
Date of filing the European patent application 2012-11-15
(97) Date of publication of the European application 2014-09-24
(45) Date of publication and mention of the grant of the patent 2019-09-11
(46) Date of publication of the claims translation 2019-11-11
PCT application
(86) Number PCT/EP2012/072699
Date 2012-11-15
PCT application publication
(87) Number WO 2013/072406
Date 2013-05-23
Priority applications
(30) Number Date Country code
201161560144 P 2011-11-15 US
201161560149 P 2011-11-15 US
201161560162 P 2011-11-15 US
201161560178 P 2011-11-15 US
201161560183 P 2011-11-15 US
201261651486 P 2012-05-24 US
201261651474 P 2012-05-24 US
Inventors
(72)
KUFER, Peter, DE
RAUM, Tobias, DE
HOFFMANN, Patrick, DE
KISCHEL, Roman, DE
LUTTERBUESE, Ralf, DE
RAU, Doris, DE
ADAM, Paul, DE
BORGES, Eric, DE
HEBEIS, Barbara, DE
HIPP, Susanne, DE
Grantee
(73) Amgen Research (Munich) GmbH, Staffelseestrasse 2, 81477 München, DE
Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Title
(54) BCMA ir CD3 prijungiančios molekulės
  BINDING MOLECULES FOR BCMA AND CD3
Last renewal fee
Payment date Validity (years) Amount
2023-10-19 12 289.00 EUR
Legal status
Patent revoked (after opposition at EPO)
Invalidation date 2024-05-22